The US Food and Drug Administration (USFDA) has approved Sun Pharma Halol (Gujarat) facility’s New Drug Application (NDA) of XELPROSTM (latanoprost ophthalmic emulsion) 0.005% for the reduction of elevated intraocular pressure (IOP, or pressure inside the eye) in patients with...
Read moreDetails


